Since TXNIP mediates inflammatory responses by binding the NLRP3 inflammasome, we also used intravitreal injection of MCC950, an NLRP3 inhibitor, to indirectly observe the relationship between TXNIP and neuropathy in glaucoma. Here, NLRP3 is linked to glaucoma.